Allergic Rhinitis in Remission after House Dust Mite Subcutaneous Immunotherapy

被引：0
|
作者：
Harintajinda, Supamas [1 ]
Kiewngam, Potjanee [2 ]
Jotikasthira, Wanlapa [2 ]
Sawatchai, Adithep [2 ]
Klangkalya, Natchanun [1 ]
Kanchongkittiphon, Watcharoot [3 ]
Manuyakorn, Wiparat [1 ]
机构：
[1] Ramathibodhi Hosp, Bangkok, Thailand
[2] Mahidol Univ, Ramathibodi Hosp, Bangkok, Thailand
[3] Mahidol Univ, Bangkok, Thailand
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2023年 / 151卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
143
引用
收藏
页码：AB47 / AB47
页数：1
相关论文
共 50 条
  • [21] ALLERGIC RHINITIS DUE TO HOUSE DUST MITE
    VIPULAKOM, P
    LEKHAVAT, T
    ATTAKORN, N
    JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, 1979, 62 (05): : 252 - 259
  • [22] Efficacy and safety of subcutaneous immunotherapy with house dust mite for allergic rhinitis: A Meta-analysis of Randomized Controlled Trials
    Huang, Yanran
    Wang, Chengshuo
    Wang, Xiangdong
    Zhang, Luo
    Lou, Hongfei
    ALLERGY, 2019, 74 (01) : 189 - 192
  • [23] Predictive methods for efficacy of house dust mite subcutaneous immunotherapy in allergic rhinitis patients: a prospective study in a Chinese population
    Liu, Zhuofu
    Lu, Hanyu
    Feng, Xian
    Hu, Li
    Wang, Jingjing
    Yu, Hongmeng
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2020, 10 (03) : 314 - 319
  • [24] Real-world evidence of subcutaneous allergoid immunotherapy in house dust mite-induced allergic rhinitis and asthma
    Jutel, Marek
    Brueggenjuergen, Bernd
    Richter, Hartmut
    Vogelberg, Christian
    ALLERGY, 2020, 75 (08) : 2050 - 2058
  • [25] Dose finding study with a subcutaneous specific immunotherapy allergoid in patients with house dust mite induced allergic rhinitis/rhinoconjunctivitis
    Pfaar, O.
    Nell, M. J.
    Boot, J. D.
    Opstelten, D. J. E.
    Versteeg, S. A.
    van Ree, R.
    Roger, A.
    Riechelmann, H.
    Elberink, Oude J. N. G.
    Bachert, C.
    ALLERGY, 2014, 69 : 187 - 187
  • [26] Long-term effects of allergen-specific subcutaneous immunotherapy for house dust mite induced allergic rhinitis
    Sahin, E.
    Dizdar, D.
    Dinc, M. E.
    Cirik, A. A.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2017, 131 (11): : 997 - 1001
  • [27] Sustained benefit of a 3-year cycle of subcutaneous house dust mite immunotherapy in local allergic rhinitis individuals
    Eguiluz-Gracia, Ibon
    Jurado-Escobar, Raquel
    Palomares Jerez, Maria Francisca
    Fernandez-Santamaraa, Ruben
    Testera Montes, Almudena
    Ariza Veguillas, Adriana
    Cornejo-Garcia, Jose
    Mayorga, Cristobalina
    Rondon Segovia, Carmen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB51 - AB51
  • [28] Clinical efficacy and safety of combined house dust mite subcutaneous immunotherapy and omalizumab in five cases of allergic rhinitis and asthma
    Kathuria, P. C.
    Rai, Manisha
    INDIAN JOURNAL OF MEDICAL SPECIALITIES, 2021, 12 (03) : 175 - 178
  • [29] House dust mite sublingual tablets (Actair®): a guide to their use as allergy immunotherapy for house dust mite-induced allergic rhinitis
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2016, 32 (6) : 219 - 225
  • [30] The effects of house dust mite sublingual immunotherapy in patients with allergic rhinitis according to duration
    Lin, Zhibin
    Liu, Qihong
    Li, Tianying
    Chen, Dong
    Chen, Dehua
    Xu, Rui
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2016, 6 (01) : 82 - 87
12345